WorldQuant Millennium Advisors
NBIX icon

WorldQuant Millennium Advisors’s Neurocrine Biosciences NBIX Stock Holding History

WorldQuant Millennium Advisors’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44M Buy
261,299
+23,395
+10% +$3.47M 0.15% 161
2026
Q1 		$31.3M Buy
237,904
+149,658
+170% +$19.9M 0.12% 177
2025
Q4 		$12.5M Buy
88,246
+26,226
+42% +$3.8M 0.05% 251
2025
Q3 		$8.71M Buy
+62,020
New +$8.4M 0.04% 256
2025
Q1 		– Sell
-154,852
Closed -$21.1M – 481
2024
Q4 		$21.1M Buy
154,852
+47,370
+44% +$5.86M 0.14% 177
2024
Q3 		$12.4M Sell
107,482
-51,003
-32% -$6.99M 0.09% 215
2024
Q2 		$21.8M Buy
158,485
+89,024
+128% +$12.2M 0.2% 142
2024
Q1 		$9.58M Buy
69,461
+50,766
+272% +$6.93M 0.12% 198
2023
Q4 		$2.46M Sell
18,695
-3,031
-14% -$349K 0.03% 264
2023
Q3 		$2.44M Sell
21,726
-97,430
-82% -$10.3M 0.04% 267
2023
Q2 		$11.2M Sell
119,156
-149,155
-56% -$14.6M 0.19% 161
2023
Q1 		$27.2M Buy
268,311
+17,239
+7% +$1.79M 0.5% 74
2022
Q4 		$30M Buy
251,072
+160,466
+177% +$18.8M 0.68% 35
2022
Q3 		$9.62M Buy
+90,606
New +$9.19M 0.23% 131
2020
Q3 		– Sell
-103,004
Closed -$12.6M – 352
2020
Q2 		$12.6M Sell
103,004
-30,740
-23% -$3.4M 0.29% 116
2020
Q1 		$11.6M Buy
133,744
+128,234
+2,327% +$12.5M 0.28% 116
2019
Q4 		$592K Buy
+5,510
New +$577K 0.01% 297

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WorldQuant Millennium Advisors's NBIX Position: Q2 2026 in Review

WorldQuant Millennium Advisors increased its Neurocrine Biosciences (NBIX) stake by 9.8% in Q2 2026, buying an estimated $3.47M and bringing the position to 261,299 shares worth $44M. The position accounts for 0.15% of the portfolio, ranked #161.

WorldQuant Millennium Advisors first reported a position in NBIX in Q4 2019 and has held it in 17 quarters since. 777 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • WorldQuant Millennium Advisors held 261,299 shares of Neurocrine Biosciences worth $44M as of Q2 2026.
  • WorldQuant Millennium Advisors bought 23,395 Neurocrine Biosciences shares in Q2 2026, an estimated $3.47M.
  • Neurocrine Biosciences made up 0.15% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #161 holding.
  • WorldQuant Millennium Advisors first reported a position in Neurocrine Biosciences in Q4 2019 and has held it in 17 quarters since.
  • 777 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.